Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 3 » Issue 2
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4184)
- Volume 20, 2024 (78)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 3, 2007
An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration
Xinhua S Ren, Shirley Qian, Lewis E Kazis
Neuropsychiatric Disease and Treatment 2007, 3:277-284
Published Date: 15 May 2007
Clinical variables and implications of the personality on the outcome of bipolar illness: a pilot study
Nieves Casas-Barquero, Olga García-López, Pedro Fernández-Argüelles, Manuel Camacho-Laraña
Neuropsychiatric Disease and Treatment 2007, 3:269-275
Published Date: 15 May 2007
Glatiramer acetate in the treatment of multiple sclerosis
Alex Tselis, Omar Khan, Robert P Lisak
Neuropsychiatric Disease and Treatment 2007, 3:259-267
Published Date: 15 May 2007
Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
Rajesh R Tampi, Christopher H van Dyck
Neuropsychiatric Disease and Treatment 2007, 3:245-258
Published Date: 15 May 2007
The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
Jeffrey R Strawn, Thomas D Geracioti Jr
Neuropsychiatric Disease and Treatment 2007, 3:237-243
Published Date: 15 May 2007
Quetiapine in the treatment of schizophrenia
Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Emanuel Severus, Hans-Jürgen Möller
Neuropsychiatric Disease and Treatment 2007, 3:219-235
Published Date: 15 May 2007
Rivastigmine in the treatment of patients with Alzheimer’s disease
Thomas Müller
Neuropsychiatric Disease and Treatment 2007, 3:211-218
Published Date: 15 May 2007
Duloxetine in the treatment of major depressive disorder
David J Goldstein
Neuropsychiatric Disease and Treatment 2007, 3:193-209
Published Date: 15 May 2007
Role of pregabalin in the treatment of generalized anxiety disorder
David S Baldwin, Khalil Ajel
Neuropsychiatric Disease and Treatment 2007, 3:185-191
Published Date: 15 May 2007
Editorial: Treatment of generalized anxiety disorder || FREE PAPER ||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2007, 3:183-184
Published Date: 15 May 2007